# Mach Natural Resources LP: financial statements, quarterly

MNR · NYSE · CIK 1980088 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mnr.md) · [Financials](/companies/mnr/financials.md) · [Filings](/companies/mnr/filings.md) · [Insiders](/companies/mnr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mnr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [175](/filings/0001628280-24-047202.md) | [228 d](/filings/0001628280-26-017249.md) | [239](/filings/0001628280-25-023787.md) | [240](/filings/0001628280-25-038877.md) | [256](/filings/0001628280-25-050305.md) | [235 d](/filings/0001628280-26-017249.md) | [227](/filings/0001628280-26-032065.md) | [289](/filings/0001628280-26-054263.md) | [273](/filings/0001628280-25-050305.md) | [388 d](/filings/0001628280-26-017249.md) | [286](/filings/0001628280-26-032065.md) | [406](/filings/0001628280-26-054263.md) |
| Operating income | $m | [83.7](/filings/0001628280-24-047202.md) | [102 d](/filings/0001628280-26-017249.md) | [67.2](/filings/0001628280-25-023787.md) | [70.5](/filings/0001628280-25-038877.md) | [94.7](/filings/0001628280-25-050305.md) | [58.5 d](/filings/0001628280-26-017249.md) | [51.7](/filings/0001628280-26-032065.md) | [111](/filings/0001628280-26-054263.md) | [(19.2)](/filings/0001628280-25-050305.md) | [101 d](/filings/0001628280-26-017249.md) | [(9.7)](/filings/0001628280-26-032065.md) | [122](/filings/0001628280-26-054263.md) |
| Interest expense | $m | [2.1](/filings/0001628280-24-047202.md) | [5.4 d](/filings/0001628280-24-014131.md) | [26.3](/filings/0001628280-24-022957.md) | [27.0](/filings/0001628280-24-036971.md) | [26.8](/filings/0001628280-24-047202.md) | [24.5 d](/filings/0001628280-26-017249.md) | [17.9](/filings/0001628280-26-032065.md) | [12.1](/filings/0001628280-26-054263.md) | [16.9](/filings/0001628280-25-050305.md) | [25.3 d](/filings/0001628280-26-017249.md) | [24.4](/filings/0001628280-26-032065.md) | [24.5](/filings/0001628280-26-054263.md) |
| Net income | $m | [83.5](/filings/0001628280-24-047202.md) | [(184) d](/filings/0001628280-26-017249.md) | [41.7](/filings/0001628280-25-050305.md) | [39.5](/filings/0001628280-25-050305.md) | [67.4](/filings/0001628280-25-050305.md) | [36.5 d](/filings/0001628280-26-017249.md) | [15.9](/filings/0001628280-26-054263.md) | [89.7](/filings/0001628280-26-054263.md) | [(35.7)](/filings/0001628280-25-050305.md) | [73.1 d](/filings/0001628280-26-017249.md) | [(35.0)](/filings/0001628280-26-054263.md) | [98.2](/filings/0001628280-26-054263.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.44](/filings/0001628280-25-023787.md) | [0.42](/filings/0001628280-25-038877.md) | [0.70](/filings/0001628280-25-050305.md) | not reported | [0.14](/filings/0001628280-26-032065.md) | [0.76](/filings/0001628280-26-054263.md) | [(0.28)](/filings/0001628280-25-050305.md) | not reported | [(0.21)](/filings/0001628280-26-032065.md) | [0.58](/filings/0001628280-26-054263.md) |
| Basic EPS | $ per share | not reported | not reported | [0.44](/filings/0001628280-25-023787.md) | [0.42](/filings/0001628280-25-038877.md) | [0.70](/filings/0001628280-25-050305.md) | not reported | [0.14](/filings/0001628280-26-032065.md) | [0.76](/filings/0001628280-26-054263.md) | [(0.28)](/filings/0001628280-25-050305.md) | not reported | [(0.21)](/filings/0001628280-26-032065.md) | [0.59](/filings/0001628280-26-054263.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [58.7](/filings/0001628280-23-041085.md) | [153](/filings/0001628280-25-012591.md) | [151](/filings/0001628280-24-022957.md) | [145](/filings/0001628280-24-036971.md) | [185](/filings/0001628280-24-047202.md) | [106](/filings/0001628280-26-017249.md) | [7.8](/filings/0001628280-25-023787.md) | [13.8](/filings/0001628280-25-038877.md) | [53.6](/filings/0001628280-25-050305.md) | [42.6](/filings/0001628280-26-054263.md) | [52.7](/filings/0001628280-26-032065.md) | [41.2](/filings/0001628280-26-054263.md) |
| Current assets | $m | [170](/filings/0001628280-23-041085.md) | [344](/filings/0001628280-25-012591.md) | [354](/filings/0001628280-24-022957.md) | [335](/filings/0001628280-24-036971.md) | [380](/filings/0001628280-24-047202.md) | [322](/filings/0001628280-26-017249.md) | [196](/filings/0001628280-25-023787.md) | [209](/filings/0001628280-25-038877.md) | [375](/filings/0001628280-25-050305.md) | [378](/filings/0001628280-26-054263.md) | [342](/filings/0001628280-26-032065.md) | [317](/filings/0001628280-26-054263.md) |
| Total assets | $m | [1,055](/filings/0001628280-23-041085.md) | [2,305](/filings/0001628280-25-012591.md) | [2,316](/filings/0001628280-24-022957.md) | [2,235](/filings/0001628280-24-036971.md) | [2,326](/filings/0001628280-24-047202.md) | [2,338](/filings/0001628280-26-017249.md) | [2,242](/filings/0001628280-25-023787.md) | [2,334](/filings/0001628280-25-038877.md) | [3,772](/filings/0001628280-25-050305.md) | [3,777](/filings/0001628280-26-054263.md) | [3,693](/filings/0001628280-26-032065.md) | [3,675](/filings/0001628280-26-054263.md) |
| Current liabilities | $m | [136](/filings/0001628280-23-041085.md) | [275](/filings/0001628280-25-012591.md) | [353](/filings/0001628280-24-022957.md) | [320](/filings/0001628280-24-036971.md) | [306](/filings/0001628280-24-047202.md) | [352](/filings/0001628280-26-017249.md) | [282](/filings/0001628280-25-023787.md) | [266](/filings/0001628280-25-038877.md) | [375](/filings/0001628280-25-050305.md) | [360](/filings/0001628280-26-054263.md) | [411](/filings/0001628280-26-032065.md) | [362](/filings/0001628280-26-054263.md) |
| Long-term debt | $m | [91.9](/filings/0001628280-23-041085.md) | [745](/filings/0001628280-25-012591.md) | [726](/filings/0001628280-24-022957.md) | [707](/filings/0001628280-24-036971.md) | [688](/filings/0001628280-24-047202.md) | [669](/filings/0001628280-26-017249.md) | [460](/filings/0001628280-25-023787.md) | [565](/filings/0001628280-25-038877.md) | [1,144](/filings/0001628280-25-050305.md) | [1,144](/filings/0001628280-26-054263.md) | [1,135](/filings/0001628280-26-032065.md) | [1,170](/filings/0001628280-26-054263.md) |
| Current portion of debt | $m | not reported | [61.9](/filings/0001628280-25-012591.md) | [82.5](/filings/0001628280-24-022957.md) | [82.5](/filings/0001628280-24-036971.md) | [82.5](/filings/0001628280-24-047202.md) | [82.5](/filings/0001628280-26-017249.md) | [0.0](/filings/0001628280-25-023787.md) | [0.0](/filings/0001628280-25-038877.md) | [0.0](/filings/0001628280-25-050305.md) | [0.0](/filings/0001628280-26-017249.md) | not reported | not reported |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [107 d](/filings/0001628280-24-047202.md) | [110 d](/filings/0001628280-26-017249.md) | [144](/filings/0001628280-25-023787.md) | [117 d](/filings/0001628280-25-038877.md) | [111 d](/filings/0001628280-25-050305.md) | [134 d](/filings/0001628280-26-017249.md) | [143](/filings/0001628280-26-032065.md) | [130 d](/filings/0001628280-26-054263.md) | [106 d](/filings/0001628280-25-050305.md) | [129 d](/filings/0001628280-26-017249.md) | [170](/filings/0001628280-26-032065.md) | [154 d](/filings/0001628280-26-054263.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [95.0](/filings/0001628280-25-023787.md) | [95.2](/filings/0001628280-25-038877.md) | [97.0](/filings/0001628280-25-050305.md) | [112](/filings/0001628280-26-032065.md) | [118](/filings/0001628280-26-054263.md) | [126](/filings/0001628280-25-050305.md) | [168](/filings/0001628280-26-032065.md) | [168](/filings/0001628280-26-054263.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 166,948,094 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054263.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.